US Stock MarketDetailed Quotes

AKTX Akari Therapeutics

Watchlist

1.6350
+0.1850+12.76%

Close May 9 16:00 ET

12.96MMarket Cap-817P/E (TTM)

Akari Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(FY)Dec 31, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

(FY)Dec 31, 2021

(Q4)Dec 31, 2021

(Q3)Sep 30, 2021

(Q2)Jun 30, 2021

(Q1)Mar 31, 2021

(FY)Dec 31, 2020

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

-27.21%16.81M

34.12%23.09M

34.32%5.82M

-5.49%5.24M

-4.26%17.21M

5.87M

492.75%1.46M

-26.75%4.33M

12.62%5.55M

6.00%17.98M

Selling and administrative expenses

-16.05%11.36M

67.40%13.53M

38.12%2.97M

53.74%3.1M

-11.79%8.08M

--2.02M

2.94%1.89M

-25.75%2.15M

-8.00%2.02M

11.39%9.16M

-General and administrative expense

-16.05%11.36M

67.40%13.53M

38.12%2.97M

53.74%3.1M

-11.79%8.08M

--2.02M

2.94%1.89M

-25.75%2.15M

-8.00%2.02M

11.39%9.16M

Research and development costs

-43.00%5.45M

4.68%9.56M

30.58%2.85M

-39.38%2.14M

3.55%9.13M

--3.85M

72.99%-430.16K

-27.71%2.18M

29.18%3.53M

0.92%8.82M

Operating profit

27.21%-16.81M

-34.12%-23.09M

-34.32%-5.82M

5.49%-5.24M

4.26%-17.21M

-5.87M

-492.75%-1.46M

26.75%-4.33M

-12.62%-5.55M

-6.00%-17.98M

Net non-operating interest income expense

78.26%82K

333.96%46K

161.06%3.96K

16.79%4.36K

-22.14%10.6K

3.98K

-77.64%1.37K

31.51%1.52K

269.80%3.74K

146.16%13.62K

Non-operating interest income

78.26%82K

333.96%46K

161.06%3.96K

16.79%4.36K

-22.14%10.6K

--3.98K

-77.64%1.37K

31.51%1.52K

269.80%3.74K

146.16%13.62K

Other net income (expense)

26.86%6.72M

2,498.72%5.29M

840.76%132.22K

121.54%63.23K

-124.92%-220.7K

80.04K

-99.08%10.67K

98.83%-17.85K

-124.87%-293.57K

695.20%885.74K

Gain on sale of security

23.90%6.74M

2,913.39%5.44M

1,208.86%141.42K

124.61%70.34K

-121.29%-193.22K

--91.17K

-98.77%14.22K

99.17%-12.75K

-124.17%-285.85K

589.30%907.75K

Other non- operating income (expenses)

86.62%-19K

-416.70%-142K

-80.67%-9.21K

7.82%-7.11K

-24.88%-27.48K

---11.12K

37.39%-3.55K

-192.65%-5.1K

-234.87%-7.71K

-8.38%-22.01K

Income before tax

43.61%-10.01M

-1.86%-17.75M

-30.68%-5.68M

11.34%-5.18M

-2.01%-17.42M

-5.79M

-258.89%-1.45M

41.58%-4.35M

-55.88%-5.84M

-1.40%-17.08M

Income tax

Net income

43.61%-10.01M

-1.86%-17.75M

-30.68%-5.68M

11.34%-5.18M

-2.01%-17.42M

-5.79M

-258.89%-1.45M

41.58%-4.35M

-55.88%-5.84M

-1.40%-17.08M

Net income continuous Operations

43.61%-10.01M

-1.86%-17.75M

-30.68%-5.68M

11.34%-5.18M

-2.01%-17.42M

---5.79M

-258.89%-1.45M

41.58%-4.35M

-55.88%-5.84M

-1.40%-17.08M

Minority interest income

Net income attributable to the parent company

43.61%-10.01M

-1.86%-17.75M

-30.68%-5.68M

11.34%-5.18M

-2.01%-17.42M

-5.79M

-258.89%-1.45M

41.58%-4.35M

-55.88%-5.84M

-1.40%-17.08M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

43.61%-10.01M

-1.86%-17.75M

-30.68%-5.68M

11.34%-5.18M

-2.01%-17.42M

-5.79M

-258.89%-1.45M

41.58%-4.35M

-55.88%-5.84M

-1.40%-17.08M

Basic earnings per share

64.03%-2.0447

29.98%-5.6853

15.28%-1.9141

36.34%-1.9321

59.40%-8.1192

-2.4904

-215.82%-0.6248

54.41%-2.2594

-1.95%-3.0351

0.00%-20

Diluted earnings per share

64.03%-2.0447

29.98%-5.6853

15.28%-1.9141

36.34%-1.9321

59.40%-8.1192

-2.4904

-215.82%-0.6248

54.41%-2.2594

-1.95%-3.0351

0.00%-20

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2023	(FY)Dec 31, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022	(FY)Dec 31, 2021	(Q4)Dec 31, 2021	(Q3)Sep 30, 2021	(Q2)Jun 30, 2021	(Q1)Mar 31, 2021	(FY)Dec 31, 2020
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-27.21%16.81M	34.12%23.09M	34.32%5.82M	-5.49%5.24M	-4.26%17.21M	5.87M	492.75%1.46M	-26.75%4.33M	12.62%5.55M	6.00%17.98M
Selling and administrative expenses	-16.05%11.36M	67.40%13.53M	38.12%2.97M	53.74%3.1M	-11.79%8.08M	--2.02M	2.94%1.89M	-25.75%2.15M	-8.00%2.02M	11.39%9.16M
-General and administrative expense	-16.05%11.36M	67.40%13.53M	38.12%2.97M	53.74%3.1M	-11.79%8.08M	--2.02M	2.94%1.89M	-25.75%2.15M	-8.00%2.02M	11.39%9.16M
Research and development costs	-43.00%5.45M	4.68%9.56M	30.58%2.85M	-39.38%2.14M	3.55%9.13M	--3.85M	72.99%-430.16K	-27.71%2.18M	29.18%3.53M	0.92%8.82M
Operating profit	27.21%-16.81M	-34.12%-23.09M	-34.32%-5.82M	5.49%-5.24M	4.26%-17.21M	-5.87M	-492.75%-1.46M	26.75%-4.33M	-12.62%-5.55M	-6.00%-17.98M
Net non-operating interest income expense	78.26%82K	333.96%46K	161.06%3.96K	16.79%4.36K	-22.14%10.6K	3.98K	-77.64%1.37K	31.51%1.52K	269.80%3.74K	146.16%13.62K
Non-operating interest income	78.26%82K	333.96%46K	161.06%3.96K	16.79%4.36K	-22.14%10.6K	--3.98K	-77.64%1.37K	31.51%1.52K	269.80%3.74K	146.16%13.62K
Other net income (expense)	26.86%6.72M	2,498.72%5.29M	840.76%132.22K	121.54%63.23K	-124.92%-220.7K	80.04K	-99.08%10.67K	98.83%-17.85K	-124.87%-293.57K	695.20%885.74K
Gain on sale of security	23.90%6.74M	2,913.39%5.44M	1,208.86%141.42K	124.61%70.34K	-121.29%-193.22K	--91.17K	-98.77%14.22K	99.17%-12.75K	-124.17%-285.85K	589.30%907.75K
Other non- operating income (expenses)	86.62%-19K	-416.70%-142K	-80.67%-9.21K	7.82%-7.11K	-24.88%-27.48K	---11.12K	37.39%-3.55K	-192.65%-5.1K	-234.87%-7.71K	-8.38%-22.01K
Income before tax	43.61%-10.01M	-1.86%-17.75M	-30.68%-5.68M	11.34%-5.18M	-2.01%-17.42M	-5.79M	-258.89%-1.45M	41.58%-4.35M	-55.88%-5.84M	-1.40%-17.08M
Income tax
Net income	43.61%-10.01M	-1.86%-17.75M	-30.68%-5.68M	11.34%-5.18M	-2.01%-17.42M	-5.79M	-258.89%-1.45M	41.58%-4.35M	-55.88%-5.84M	-1.40%-17.08M
Net income continuous Operations	43.61%-10.01M	-1.86%-17.75M	-30.68%-5.68M	11.34%-5.18M	-2.01%-17.42M	---5.79M	-258.89%-1.45M	41.58%-4.35M	-55.88%-5.84M	-1.40%-17.08M
Minority interest income
Net income attributable to the parent company	43.61%-10.01M	-1.86%-17.75M	-30.68%-5.68M	11.34%-5.18M	-2.01%-17.42M	-5.79M	-258.89%-1.45M	41.58%-4.35M	-55.88%-5.84M	-1.40%-17.08M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	43.61%-10.01M	-1.86%-17.75M	-30.68%-5.68M	11.34%-5.18M	-2.01%-17.42M	-5.79M	-258.89%-1.45M	41.58%-4.35M	-55.88%-5.84M	-1.40%-17.08M
Basic earnings per share	64.03%-2.0447	29.98%-5.6853	15.28%-1.9141	36.34%-1.9321	59.40%-8.1192	-2.4904	-215.82%-0.6248	54.41%-2.2594	-1.95%-3.0351	0.00%-20
Diluted earnings per share	64.03%-2.0447	29.98%-5.6853	15.28%-1.9141	36.34%-1.9321	59.40%-8.1192	-2.4904	-215.82%-0.6248	54.41%-2.2594	-1.95%-3.0351	0.00%-20
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion with Explanatory Notes	Unqualified Opinion with Explanatory Notes	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall